Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000911420-04-000437
Filing Date
2004-10-26
Accepted
2004-10-26 14:13:32
Documents
1
Period of Report
2004-10-25

Document Format Files

Seq Description Document Type Size
1 p1000619_ex.html 4  
1 p1000619_ex.xml 4 4749
  Complete submission text file 0000911420-04-000437.txt   6616
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Issuer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
SIC: 8071 Services-Medical Laboratories

Mailing Address 527 MADISON AVENUE NEW YORK NY 10022
Business Address C/O ENZO BIOCHEM INC 527 MADISON AVE NEW YORK NY 10022 2125830100
THALENFELD BARBARA E (Reporting) CIK: 0001236358 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09974 | Film No.: 041096248